ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

NKTX Nkarta Inc

6.58
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:56:11
15분 지연
기업명 주식 심볼 시장 주식 타입
Nkarta Inc NKTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 6.58 20:56:11
개장가 저가 고가 종가 전일 종가
6.58
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
10/05/202405:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/05/202405:04EDGAR2Form 8-K - Current report
10/05/202405:01GLOBENkarta Reports First Quarter 2024 Financial Results and..
04/04/202405:02GLOBENkarta to Participate in Upcoming Investor Conferences
25/03/202419:30GLOBENkarta Announces Pricing of $240 Million Underwritten..
22/03/202405:01GLOBENkarta Reports Fourth Quarter and Full Year 2023 Financial..
06/03/202406:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:32EDGAR2Form 144 - Report of proposed sale of securities
28/02/202422:01GLOBENkarta to Participate in Upcoming Investor Conferences
15/02/202411:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:20EDGAR2Form 144 - Report of proposed sale of securities
09/02/202420:38EDGAR2Form SC 13D/A - General statement of acquisition of..
19/01/202406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202422:50EDGAR2Form 8-K - Current report
04/01/202406:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/12/202310:31GLOBENkarta Presents NKX101 Clinical Data at the 2023 American..
13/11/202322:25EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/11/202306:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:06EDGAR2Form 8-K - Current report
10/11/202306:02GLOBENkarta Reports Third Quarter 2023 Financial Results and..
07/11/202322:02GLOBENkarta to Participate at Upcoming Investor Conferences
28/10/202305:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/10/202301:00DJNNkarta's Stock Climbs 28% After FDA Approves Drug..
18/10/202300:47PRNUSLupus Therapeutics Announces Partnership to Support the..
17/10/202320:06EDGAR2Form 8-K - Current report
17/10/202320:01GLOBENkarta Receives FDA Clearance of IND Application for NKX019..
17/10/202305:07EDGAR2Form 8-K - Current report
17/10/202305:01GLOBENkarta to Host Conference Call on Tuesday, October 17 at 8am..
24/08/202305:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202320:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202320:05EDGAR2Form 8-K - Current report
10/08/202320:01GLOBENkarta Reports Second Quarter 2023 Financial Results and..
03/08/202321:02GLOBENkarta to Participate at Upcoming Investor Conference
06/07/202305:09EDGAR2Form 8-K - Current report
06/07/202305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/07/202305:02GLOBENkarta Appoints Alyssa Levin Chief Financial and Business..
27/06/202320:01GLOBENkarta Updates Clinical Progress of CAR-NK Cell Therapy..
27/06/202305:01GLOBENkarta to Host Conference Call to Discuss Updated Clinical..
10/06/202323:47GLOBENkarta Presents NKX019 Clinical Data at the European..

최근 히스토리

Delayed Upgrade Clock